Abstract: An example system includes a light intensity measuring apparatus couplable to a food processing apparatus and a computing system. The light intensity measuring apparatus includes a chamber configured to receive a water sample from the food processing apparatus, a light source, a detector configured to detect light that has passed through the water sample and measure multiple times intensities of wavelengths of the light to obtain multiple sets of measured intensities of wavelengths, and a communication module configured to provide the multiple sets of measured intensities of wavelengths. The computing system may receive the multiple sets of measured intensities, process the multiple sets to obtain a set of values, apply a first set of decision trees to the set of values to obtain a first result indicating a positive or negative foodborne pathogen detection, generate a notification indicating either the positive of negative detection, and provide the notification.

Abstract: A clot removal device for removing at least one clot from an inside of a blood vessel having a bifurcation. The clot removal device includes a clot removal member, configured to be positioned at the bifurcation, the clot removal member including a base configured to be positioned inside the proximal blood vessel, and two anchoring members, wherein at least one of the anchoring members is configured to be positioned inside at least one of the two distal blood vessels, each anchoring member including at least one self-expanding portion configured to adopt a collapsed configuration configured for navigating the clot removal device inside the blood vessel, and an expanded configuration configured for anchoring to the clot.

Abstract: The present invention relates to the field of medicine and provides pharmaceutical compositions comprising one or more of the following isolated amino acid sequences comprising or, alternatively, consisting of, SEQ ID No.: 3, and/or SEQ ID No.: 1, and/or SEQ ID No.: 2, kits and conjugates comprising one or more of the above mentioned amino acid sequences. In addition, the present invention relates to the use of the pharmaceutical compositions, kits and conjugates of the present invention as a medicament, in particular in the treatment of an infectious disease, or of an inflammatory condition related to an infectious disease, or of an inflammatory disease related to the presence of a product derived from an infectious agent. The present invention also provides a device for selective binding and separation of at least one component from an aqueous solution wherein the device comprises one or more of the above mentioned amino acid sequences.

Abstract: An example method includes receiving multiple spectrometer scans of a sample obtained from a person. A spectrometer scan includes intensities of wavelengths of light in a range of wavelengths. The light has passed through at least a portion of the sample. For multiple wavelengths of light in the range of wavelengths, a particular profile intensity utilizing particular intensities of wavelengths of light included in the multiple spectrometer scans is calculated to obtain multiple profile intensities. Slopes of the multiple profile intensities at multiple wavelengths are calculated to obtain a set of slopes. A fitting function is applied to the set of slopes to obtain a set of values. A set of decision trees is applied to the set of values to obtain a result. The result indicates either a positive pathogen detection or a negative pathogen detection for the sample. A pathogen detection notification is generated indicating either the positive pathogen detection or the negative pathogen detection for the sample.

Abstract: An example system includes a light intensity measuring apparatus couplable to a food processing apparatus and a computing system. The light intensity measuring apparatus includes a chamber configured to receive a water sample from the food processing apparatus, a light source, a detector configured to detect light that has passed through the water sample and measure multiple times intensities of wavelengths of the light to obtain multiple sets of measured intensities of wavelengths, and a communication module configured to provide the multiple sets of measured intensities of wavelengths. The computing system may receive the multiple sets of measured intensities, process the multiple sets to obtain a set of values, apply a first set of decision trees to the set of values to obtain a first result indicating a positive or negative foodborne pathogen detection, generate a notification indicating either the positive of negative detection, and provide the notification.

Abstract: The present invention relates to the field of medicine and provides pharmaceutical compositions comprising one or more of the following isolated amino acid sequences comprising or, alternatively, consisting of, SEQ. ID No.: 3, and/or SEQ. ID No.: 1, and/or SEQ ID No.: 2, kits and conjugates comprising one or more of the above mentioned amino acid sequences. In addition, the present invention relates to the use of the pharmaceutical compositions, kits and conjugates of the present invention as a medicament, in particular in the treatment of an infectious disease, or of an inflammatory condition related to an infectious disease, or of an inflammatory disease related to the presence of a product derived from an infectious agent. The present invention also provides a device for selective binding and separation of at least one component from an aqueous solution wherein the device comprises one or more of the above mentioned amino acid sequences.

Abstract: The present invention relates to the field of medicine and provides compositions and kits-of-parts comprising a CD6 product and Imipenem, in particular for their use in a therapeutic and/or preventive method of treatment, in a mammal including a human, of an infectious disease, or of an inflammatory condition related to an infectious disease, or of an inflammatory disease related to the presence of a product derived from an infectious agent.

Abstract: The present invention relates to the field of medicine and provides pharmaceutical compositions comprising one or more of the following isolated amino acid sequences comprising or, alternatively, consisting of, SEQ. ID No.: 3, and/or SEQ. ID No.: 1, and/or SEQ ID No.: 2, kits and conjugates comprising one or more of the above mentioned amino acid sequences. In addition, the present invention relates to the use of the pharmaceutical compositions, kits and conjugates of the present invention as a medicament, in particular in the treatment of an infectious disease, or of an inflammatory condition related to an infectious disease, or of an inflammatory disease related to the presence of a product derived from an infectious agent. The present invention also provides a device for selective binding and separation of at least one component from an aqueous solution wherein the device comprises one or more of the above mentioned amino acid sequences.

Abstract: The present invention relates to the field of medicine and provides compositions and kits-of-parts comprising a CD6 product and Imipenem, in particular for their use in a therapeutic and/or preventive method of treatment, in a mammal including a human, of an infectious disease, or of an inflammatory condition related to an infectious disease, or of an inflammatory disease related to the presence of a product derived from an infectious agent.

Abstract: This disclosure relates to peptides useful for targeting inflamed or distressed tissue and uses related thereto. In certain embodiment, the peptides comprise SEQ ID NO: 1-14, or variants or derivatives thereof. In certain embodiments, peptides disclosed herein are conjugated to a label to detect, measure, or image cardiac tissue useful in the diagnosis of myocarditis. In certain embodiments, the peptides are conjugated to a particle coating for use in ultrasound imaging, MRI, or targeted therapy. In certain embodiments, peptides disclosed herein are conjugated to a drug or a particle containing a drug useful for targeted therapy.

Abstract: A method and system can include a program management system configured to receive inputs for variables for a digital project which include project types, resources, distribution platforms, and scope of the digital project, and to generate at least the timeline and the cost based on the received inputs for variables for the digital project, and receive a modification of at least one of the variables or receive a modification of the estimated timeline or the cost and dynamically modify the timeline or cost in response to receiving the modification of at least one of the variables or dynamically modify at least one of the variables in response to receiving the modification to the timeline or the cost. The method and system can further present timeline and the cost for the digital project after receiving the modification of at least one of the variables.

Abstract: This disclosure relates to peptides useful for targeting inflamed or distressed tissue and uses related thereto. In certain embodiment, the peptides comprise SEQ ID NO: 1-14, or variants or derivatives thereof. In certain embodiments, peptides disclosed herein are conjugated to a label to detect, measure, or image cardiac tissue useful in the diagnosis of myocarditis. In certain embodiments, the peptides are conjugated to a particle coating for use in ultrasound imaging, MRI, or targeted therapy. In certain embodiments, peptides disclosed herein are conjugated to a drug or a particle containing a drug useful for targeted therapy.

Abstract: Airborne tracking systems use sensors to track objects of interest. In order to track the objects of interests, the sensors need to be steered such that the object is kept, ideally, in the center of the sensors field of view. Automatic steering of optical sensors requires the generation of a track on an object of interest. When tracking boats on the water, current approaches to image processing may generate multiple detections on the object of interest. Embodiments of the present disclosure solve the track multiplicity problem by grouping tracks associated with the object of interest into a cluster and by estimating a most likely location of the object within the cluster of tracks. Based on the estimated location, embodiments of the present disclosure outputs a single track for the object. The single track is used by an automatic steering system to maintain a sensor aimed at the object of interest.

Abstract: Airborne tracking systems use sensors to track objects of interest. In order to track the objects of interests, the sensors need to be steered such that the object is kept, ideally, in the center of the sensors field of view. Automatic steering of optical sensors requires the generation of a track on an object of interest. When tracking boats on the water, current approaches to image processing may generate multiple detections on the object of interest. Embodiments of the present disclosure solve the track multiplicity problem by grouping tracks associated with the object of interest into a cluster and by estimating a most likely location of the object within the cluster of tracks. Based on the estimated location, embodiments of the present disclosure outputs a single track for the object. The single track is used by an automatic steering system to maintain a sensor aimed at the object of interest.

Abstract: A static random-access memory (SRAM) provides volatile storage of data in a cellular telephone. Connected to the volatile SRAM is a second SRAM that provides nonvolatile storage of data by backup battery means. Writing and reading of either volatile or nonvolatile data can occur. Additionally, provision is made to automatically back up data written to the volatile SRAM in the nonvolatile SRAM, as well as to streamline restoration of backed-up data from the nonvolatile SRAM to the volatile SRAM.

Abstract: A flip-flop having a sleep mode in which power consumption is reduced. The flip-flop comprises a clock input, a data input, an input stage, an input gate, an output stage and an output clamp. The input gate is interposed between the data input and the input stage and operates in the sleep mode to isolate the input stage from the data input. The output stage is coupled to the input stage and includes an output having a first output state and a second output state. The output clamp operates in the sleep mode to set the output stage to a predetermined state regardless of the data states at the data input and the clock input. The predetermined state is the one of the output states in which the leakage power consumption of the flip-flop is less than in the other of the output states. The predetermined state may alternatively be the one of the output states in which the leakage power consumption of circuitry connected to the output of the flip-flop is less than in the other of the output states.

Abstract: This invention relates to aircraft passenger accommodations which are easily and individually convertible from a sitting position to a reclining position. The accommodations provide privacy and security in single or double occupancy configurations.